![](https://investorshub.advfn.com/uicon/315468.png?cb=1473363790)
Thursday, April 15, 2021 6:49:04 PM
"MS Drug under Development (RPI-78M) - ReceptoPharm conducted microarray and histoculture studies and related
analysis of the cells of Multiple Sclerosis patients to ascertain how RPI-78M affected the cells of these patients."
So Deitsch has been claiming to develop RPI-78M for 15 years and there still hasn't been anything done.
Garbage like this is why Deitsch doesn't have any credibility.
IG
Get ready scammers. Hell is coming to breakfast.
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM